Literature DB >> 12673282

Inverse correlation between SMN1 and SMN2 copy numbers: evidence for gene conversion from SMN2 to SMN1.

Shuji Ogino1, Sizhen Gao, Debra G B Leonard, Michele Paessler, Robert B Wilson.   

Abstract

Most carriers of autosomal recessive spinal muscular atrophy (SMA) have only one copy of SMN1 because of SMN1 gene deletions or gene conversions from SMN1 to SMN2, which has only one base difference in coding sequence from SMN1. Using SMN gene dosage analysis, we determined the copy numbers of SMN1 and SMN2 in the general population as well as in SMA patients and carriers. Increased SMN1 copy number is associated with decreased SMN2 copy number in the general population; that is, SMN2 copy number was decreased to one or zero copies in 11 of 13 individuals with three or four copies of SMN1, whereas only 71 of 164 individuals with two copies of SMN1 had one or zero copies of SMN2 (P<0.01). SMN2 copy number was increased to three or four in a subset of SMN1 deletion/conversion carriers, and in most SMA patients with a milder phenotype. In conclusion, our data provide evidence that gene conversion from SMN2 to SMN1 occurs, and that SMN1 converted from SMN2 is present in the general population.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12673282     DOI: 10.1038/sj.ejhg.5200957

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  12 in total

1.  Detection of SMN1 to SMN2 gene conversion events and partial SMN1 gene deletions using array digital PCR.

Authors:  Deborah L Stabley; Jennifer Holbrook; Mena Scavina; Thomas O Crawford; Kathryn J Swoboda; Katherine M Robbins; Matthew E R Butchbach
Journal:  Neurogenetics       Date:  2021-01-07       Impact factor: 2.660

2.  Mildly affected patients with spinal muscular atrophy are partially protected by an increased SMN2 copy number.

Authors:  B Wirth; L Brichta; B Schrank; H Lochmüller; S Blick; A Baasner; R Heller
Journal:  Hum Genet       Date:  2006-03-01       Impact factor: 4.132

3.  Transmission characteristics of SMN from 227 spinal muscular atrophy core families in China.

Authors:  Yanyan Cao; Yujin Qu; Jinli Bai; Miaomiao Cheng; Yuwei Jin; Hong Wang; Fang Song
Journal:  J Hum Genet       Date:  2020-02-13       Impact factor: 3.172

4.  Tetracyclines that promote SMN2 exon 7 splicing as therapeutics for spinal muscular atrophy.

Authors:  Michelle L Hastings; Joel Berniac; Ying Hsiu Liu; Paul Abato; Francine M Jodelka; Lea Barthel; Sujatha Kumar; Caroline Dudley; Mark Nelson; Kelley Larson; Jason Edmonds; Todd Bowser; Michael Draper; Paul Higgins; Adrian R Krainer
Journal:  Sci Transl Med       Date:  2009-11-04       Impact factor: 17.956

5.  Clinical and Genetic Study of Algerian Patients with Spinal Muscular Atrophy.

Authors:  Y Sifi; K Sifi; A Boulefkhad; N Abadi; Z Bouderda; R Cheriet; M Magen; J P Bonnefont; A Munnich; C Benlatreche; A Hamri
Journal:  J Neurodegener Dis       Date:  2013-03-24

6.  Validation of a high resolution NGS method for detecting spinal muscular atrophy carriers among phase 3 participants in the 1000 Genomes Project.

Authors:  Jessica L Larson; Ari J Silver; Dalin Chan; Carlos Borroto; Brett Spurrier; Lee M Silver
Journal:  BMC Med Genet       Date:  2015-10-29       Impact factor: 2.103

7.  Differences in SMN1 allele frequencies among ethnic groups within North America.

Authors:  B C Hendrickson; C Donohoe; V R Akmaev; E A Sugarman; P Labrousse; L Boguslavskiy; K Flynn; E M Rohlfs; A Walker; B Allitto; C Sears; T Scholl
Journal:  J Med Genet       Date:  2009-07-21       Impact factor: 6.318

8.  Genetics of low spinal muscular atrophy carrier frequency in sub-Saharan Africa.

Authors:  Modibo Sangaré; Brant Hendrickson; Hammadoun Ali Sango; Kelian Chen; Jonathan Nofziger; Abdelbasset Amara; Amalia Dutra; Alice B Schindler; Aldiouma Guindo; Mahamadou Traoré; George Harmison; Evgenia Pak; Fatoumata N'Go Yaro; Katherine Bricceno; Christopher Grunseich; Guibin Chen; Manfred Boehm; Kristen Zukosky; Nouhoum Bocoum; Katherine G Meilleur; Fatoumata Daou; Koumba Bagayogo; Yaya Ibrahim Coulibaly; Mahamadou Diakité; Michael P Fay; Hee-Suk Lee; Ali Saad; Moez Gribaa; Andrew B Singleton; Youssoufa Maiga; Sungyoung Auh; Guida Landouré; Rick M Fairhurst; Barrington G Burnett; Thomas Scholl; Kenneth H Fischbeck
Journal:  Ann Neurol       Date:  2014-04-02       Impact factor: 10.422

9.  Pharmacokinetics, pharmacodynamics, and efficacy of a small-molecule SMN2 splicing modifier in mouse models of spinal muscular atrophy.

Authors:  Xin Zhao; Zhihua Feng; Karen K Y Ling; Anna Mollin; Josephine Sheedy; Shirley Yeh; Janet Petruska; Jana Narasimhan; Amal Dakka; Ellen M Welch; Gary Karp; Karen S Chen; Friedrich Metzger; Hasane Ratni; Francesco Lotti; Sarah Tisdale; Nikolai A Naryshkin; Livio Pellizzoni; Sergey Paushkin; Chien-Ping Ko; Marla Weetall
Journal:  Hum Mol Genet       Date:  2016-02-29       Impact factor: 6.150

10.  Infants Diagnosed with Spinal Muscular Atrophy and 4 SMN2 Copies through Newborn Screening - Opportunity or Burden?

Authors:  Wolfgang Müller-Felber; Katharina Vill; Oliver Schwartz; Dieter Gläser; Uta Nennstiel; Brunhilde Wirth; Siegfried Burggraf; Wulf Röschinger; Marc Becker; Jürgen Durner; Katja Eggermann; Christine Müller; Iris Hannibal; Bernd Olgemöller; Ulrike Schara; Astrid Blaschek; Heike Kölbel
Journal:  J Neuromuscul Dis       Date:  2020
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.